Table of Contents

company-logo

Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The company is also developing programs targeting FGFR2- intrahepatic cholangiocarcinoma,FGFR3-related achondroplasia, REarranged during transfection kinase, and FGFR4-related cancers. In addition, the company offers SNAP platform which enable rapid structural design through iterative molecular SNAPshots. Tyra Biosciences, Inc. was incorporated in 2018 and is based in Carlsbad, California.

Tyra Biosciences Dividend Announcement

• Tyra Biosciences does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Tyra Biosciences dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Tyra Biosciences Dividend History

Tyra Biosciences Dividend Yield

Tyra Biosciences current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Tyra Biosciences stock? Use our calculator to estimate your expected dividend yield:

Tyra Biosciences Financial Ratios

P/E ratio-11410.71
PEG ratio1740.13
P/B ratio2637.50
ROE-25.14%
Payout ratio0.00%
Current ratio29.55
Quick ratio29.55
Cash Ratio8.40

Tyra Biosciences Dividend FAQ

Does Tyra Biosciences stock pay dividends?
Tyra Biosciences does not currently pay dividends to its shareholders.
Has Tyra Biosciences ever paid a dividend?
No, Tyra Biosciences has no a history of paying dividends to its shareholders. Tyra Biosciences is not known for its dividend payments.
Why doesn't Tyra Biosciences pay dividends?
There are several potential reasons why Tyra Biosciences would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Tyra Biosciences ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Tyra Biosciences has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Tyra Biosciences a dividend aristocrat?
Tyra Biosciences is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Tyra Biosciences a dividend king?
Tyra Biosciences is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Tyra Biosciences a dividend stock?
No, Tyra Biosciences is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Tyra Biosciences stocks?
To buy Tyra Biosciences you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Tyra Biosciences stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.